# Directive 2006/126/EC of the European Parliament and of the Council of 20 December 2006 on driving licences (Recast) (Text with EEA relevance), Division 10.3: Consideration may be given to the issuing/renewal of group 2 licences to drivers with diabetes mellitus. When treated with medication which carries a risk of inducing hypoglycaemia (that is, with insulin, and some tablets), the following criteria should apply:

Extent: E+W+S+N.I.

no severe hypoglycaemic events have occurred in the previous 12 months,
the driver has full hypoglycaemic awareness,
the driver must show adequate control of the condition by regular blood glucose monitoring, at least twice daily and at times relevant to driving,
the driver must demonstrate an understanding of the risks of hypoglycaemia,
there are no other debarring complications of diabetes.
Moreover, in these cases, such licences should be issued subject to the opinion of a competent medical authority and to regular medical review, undertaken at intervals of not more than three years.

---
Source: https://www.legislation.gov.uk/eudr/2006/126/annex/III/division/7/division/3/division/10.3 (the official version)
Page: https://openlegislation.uk/eu-directive-2006-126/annex-III/division-7/division-3/division-10.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.